MIRATI THERAPEUTICS INC - COM (MRTX)

Historical Holders from Q1 2014 to Q2 2024

Type / Class: Equity / COM
Symbol: MRTX

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of MIRATI THERAPEUTICS INC - COM (MRTX) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2024 Q2	0	$0	-$26,433				0
2024 Q1	43	$2,525	-$4,464,062,363	$0	$0	5,871.71%	2
2023 Q4	79,275,905	$4,657,835,903	+$14,045,563	$60,054,250	$67,251,500	5,875%	214
2023 Q3	81,015,221	$3,529,100,894	+$678,498,915	$17,750,700	$55,939,752	4,356%	212
2023 Q2	65,867,654	$2,380,350,563	+$61,643,418	$6,763,536	$22,754,366	3,613%	205
2023 Q1	64,072,708	$2,379,835,109	-$56,796,001	$7,205,484	$11,890,092	3,718%	219
2022 Q4	65,482,242	$2,966,731,069	-$56,815,150	$23,488,685	$59,357,873	4,531%	231
2022 Q3	63,558,869	$4,438,430,260	+$56,071,596	$74,443,136	$62,606,384	6,984%	234
2022 Q2	62,636,989	$4,206,428,893	+$294,727,854	$17,373,998	$68,052,000	6,713%	221
2022 Q1	57,270,400	$4,709,749,015	-$96,675,294	$28,353,136	$42,016,388	8,222%	243
2021 Q4	56,810,456	$8,331,650,740	+$260,316,448	$46,684,714	$95,827,000	14,669%	248
2021 Q3	54,192,030	$9,586,786,560	+$202,014,736	$84,609,446	$235,322,132	17,690.94%	235
2021 Q2	53,049,085	$8,569,104,822	-$95,645,396	$38,171,703	$87,648,000	16,153%	241
2021 Q1	50,069,930	$8,578,534,607	+$129,172,057	$81,247,790	$110,557,840	17,130%	254
2020 Q4	49,366,833	$10,842,833,809	+$883,958,730	$96,204,312	$196,538,704	21,964%	279
2020 Q3	45,064,639	$7,483,008,247	+$24,152,868	$164,123,000	$123,175,000	16,605%	220
2020 Q2	48,512,828	$5,541,580,994	+$25,678,805	$56,390,000	$31,512,000	11,417%	197
2020 Q1	48,359,658	$3,716,493,515	+$432,192,189	$46,368,000	$88,422,000	7,687%	172
2019 Q4	42,695,607	$5,501,745,630	-$10,050,805	$96,245,000	$203,680,000	12,886.02%	188
2019 Q3	43,125,129	$3,360,052,841	-$42,534,401	$140,692,000	$202,301,000	7,791%	175
2019 Q2	43,518,939	$4,482,447,997	+$459,732,098	$95,853,000	$189,654,000	10,300%	170
2019 Q1	40,403,218	$2,961,551,852	+$372,725,379	$19,182,000	$35,505,000	7,330%	157
2018 Q4	35,494,849	$1,505,586,755	+$76,254,622	$2,808,000	$5,222,000	4,241.98%	111
2018 Q3	33,576,080	$1,581,467,120	+$87,519,242	$31,284,000	$29,133,000	4,710.01%	124
2018 Q2	31,664,389	$1,561,052,597	+$378,856,232	$5,955,000	$12,365,000	4,930%	107
2018 Q1	24,644,153	$756,571,000	+$76,109,550	$1,318,000	$1,167,000	3,069.99%	81
2017 Q4	22,370,910	$408,287,000	+$89,912,664	$192,000	$1,588,000	1,824.99%	63
2017 Q3	17,456,431	$204,269,023	+$75,973,900	$729,000	$2,455,000	1,170%	49
2017 Q2	12,143,615	$44,314,007	-$5,841,679	$17,000		365%	49
2017 Q1	13,282,064	$69,065,474	+$12,019,529	$116,000	$43,000	520%	62
2016 Q4	11,885,786	$56,460,551	-$2,257,015	$83,000		475.03%	61
2016 Q3	12,201,483	$80,653,157	-$7,849,525	$2,000	$1,000	661.01%	68
2016 Q2	13,824,495	$75,479,942	-$45,208,212	$146,000		545.98%	69
2016 Q1	16,427,964	$351,768,280	+$11,190,278	$0		2,140%	67
2015 Q4	15,804,041	$499,358,154	-$22,962,034	$1,324,000	$0	3,160%	80
2015 Q3	13,908,715	$478,724,901	+$100,981,469	$2,069,000	$2,471,000	3,442.02%	78
2015 Q2	11,011,215	$346,520,042	+$4,615,088	$538,000	$447,000	3,147%	66
2015 Q1	10,895,634	$319,455,068	+$81,152,798			2,932%	57
2014 Q4	8,138,866	$149,916,544	+$527,103			1,852.01%	44
2014 Q3	8,038,951	$140,455,223	-$1,813,415			1,750.98%	43
2014 Q2	8,133,973	$162,482,860	-$17,308,007			2,000%	44
2014 Q1	9,037,720	$172,344,000	+$9,862,539			1,906.98%	30